The molybdenum nitrogenase, present in a diverse group of bacteria and archea, is the major contributor to biological nitrogen fixation. The nitrogenase active site contains an iron-molybdenum cofactor (FeMo-co) composed of 7Fe, 9S, 1Mo, one unidentified light atom, and homocitrate. The nifQ gene was known to be involved in the incorporation of molybdenum into nitrogenase. Here we show direct biochemical evidence for the role of NifQ in FeMo-co biosynthesis. As-isolated NifQ was found to carry a molybdenum-iron-sulfur cluster that serves as a specific molybdenum donor for FeMo-co biosynthesis. Purified NifQ supported in vitro FeMo-co synthesis in the absence of an additional molybdenum source. The mobilization of molybdenum from NifQ required the simultaneous participation of NifH and NifEN in the in vitro FeMo-co synthesis assay, suggesting that NifQ would be the physiological molybdenum donor to a hypothetical NifEN/NifH complex.
The molybdenum nitrogenase, present in a diverse group of bacteria and archea, is the major contributor to biological nitrogen fixation. The nitrogenase active site contains an iron-molybdenum cofactor (FeMo-co) composed of 7Fe, 9S, 1Mo, one unidentified light atom, and homocitrate. The nifQ gene was known to be involved in the incorporation of molybdenum into nitrogenase. Here we show direct biochemical evidence for the role of NifQ in FeMo-co biosynthesis. As-isolated NifQ was found to carry a molybdenum-iron-sulfur cluster that serves as a specific molybdenum donor for FeMo-co biosynthesis. Purified NifQ supported in vitro FeMo-co synthesis in the absence of an additional molybdenum source. The mobilization of molybdenum from NifQ required the simultaneous participation of NifH and NifEN in the in vitro FeMo-co synthesis assay, suggesting that NifQ would be the physiological molybdenum donor to a hypothetical NifEN/NifH complex.
nif ͉ iron-sulfur cluster ͉ Azotobacter vinelandii B iological nitrogen fixation performed by microorganisms that have nitrogenase(s) accounts for roughly two-thirds of the nitrogen fixed globally. Most nitrogen fixation is carried out by the activity of molybdenum nitrogenase (1) , which is widely distributed in nature (2) . The molybdenum-nitrogenase enzyme is composed of two proteins (3): a heterotetrameric NifDKprotein component (a 2 ␤ 2 dinitrogenase) and a homodimeric NifH-protein component (dinitrogenase reductase). NifDK contains one iron-molybdenum cofactor (FeMo-co) within the active site of each ␣-subunit (NifD), and one [8Fe-7S] P-cluster at the interface of the ␣-and ␤-subunits in each ␣␤ pair (4) . NifH contains a [4Fe-4S] cluster bridging the two subunits and one site for Mg-ATP binding and hydrolysis in each subunit (5) .
FeMo-co is a unique cofactor ʈ composed of a [Mo-3Fe-3S] partial cubane bridged to a [4Fe-3S] partial cubane by three sulfur ligands and one unidentified light atom in the center of the cofactor (6) . The molybdenum atom is also coordinated to the organic acid homocitrate. The biosynthesis of FeMo-co is a complex process that involves the activities of several nitrogen fixation (nif ) gene products that function as molecular scaffolds, enzymes, or escort proteins that carry FeMo-co precursors between assembly sites in the pathway (7, 8) . Following assembly, FeMo-co is inserted into apo-NifDK, a P-cluster-containing but FeMo-co-deficient form of NifDK that is matured into functional NifDK simply by FeMo-co insertion, to generate the mature dinitrogenase enzyme that is competent for nitrogen fixation.
The NifEN scaffold protein is believed to function in the pathway as a central node to which an [Fe-S]-containing FeMo-co precursor, molybdenum, and homocitrate might converge to complete the assembly of FeMo-co (9) (10) (11) (12) . In this model, the [Fe-S]-containing FeMo-co precursor, NifB-co**, would be initially assembled by NifB and then transferred to NifEN for its conversion into the [Fe-S] VK-cluster (13, 14) . Homocitrate would be provided by the homocitrate-synthase activity of NifV (15, 16) . Although molybdate satisfies the molybdenum requirement for FeMo-co synthesis in vitro, the physiological source of molybdenum remains unknown.
Genetic evidence from Azotobacter vinelandii, Klebsiella pneumoniae, and other nitrogen-fixing bacteria has suggested the involvement of NifQ in molybdenum processing for nitrogenase. In all cases tested, nifQ has been shown to be essential for diazotrophic growth, although excess molybdate in the growth medium alleviated the nifQ phenotype (17) (18) (19) . The role of NifQ is specifically related to the Mo-nitrogenase because nifQ mutants were not affected in either the capacity to grow by using the alternative vanadium or iron-only nitrogenase systems (20) or in the activity of molybdopterin-containing enzymes (21) .
NifQ homologues are present in all diazotrophic species of the Proteobacteria phylum, with the exception of some Rhizobium species. NifQ proteins have a conserved Cx 4 Cx 2 Cx 5 C amino acid motif that has been suggested to bind a molybdenum-containing metal cluster or a Mo-S intermediate for FeMo-co synthesis (22) . However, NifQ proteins are unique and their primary sequences are unrelated to other proteins shown to be involved in molybdenum trafficking. NifQ proteins do not carry molbindin-like domains that are involved in molybdate binding (23) . Molbindin domains are found in the ModA component of molybdatetransport systems, in the molybdate-responsive ModE transcriptional regulator, and in the A. vinelandii ModG protein involved in molybdenum homeostasis. Additionally, NifQ does not exhibit significant sequence similarity to the molybdenum-storageprotein (Mosto) MosA and MosB polypeptide components, which are able to bind large amounts of molybdenum, presumably as heptamolybdate (24) .
In this work, we show that NifQ carries a molybdenum-ironsulfur cluster that serves as a specific molybdenum donor for the synthesis of FeMo-co in vitro. Mobilization of molybdenum from NifQ required the simultaneous presence of the NifH and NifEN proteins. These findings strongly support a role for NifQ as the physiological molybdenum donor to a putative NifEN/NifH complex during FeMo-co biosynthesis.
Results
NifQ Is an Iron-Sulfur Molybdoprotein. Expression of a His-tagged version of NifQ in UW300 cells was 50-fold higher than NifQ expression in wild-type cells. His-NifQ overexpression did not alter in vitro nitrogenase activity [supporting information (SI) Table S1 ] or the regulation by ammonium of the expression of NifQ or any other essential nif gene analyzed in UW300 (data not shown). Hereafter, we refer to the A. vinelandii His-tagged NifQ variant as NifQ. The NifQ protein was purified under strict anaerobic conditions from UW300 cells (Fig. 1A and Experimental Procedures). The average purification yield was 280 mg NifQ/kg UW300 cell paste. The A. vinelandii NifQ was also purified from recombinant Escherichia coli cells overexpressing GST-NifQ fusion protein (Fig. 1B) . NifQ protein purified from E. coli cells was denominated as rNifQ. The average purification yield was 4 g rNifQ/kg E. coli cell paste.
NifQ and rNifQ preparations were reddish brown and exhibited a positive signal in gels stained for Fe after anoxic native PAGE (Fig. 1C) . Exposure of the purified proteins to air resulted in color bleaching indicative of sensitivity to oxygen (data not shown). The native molecular weight of as-isolated NifQ (M r ϭ 25.7 Ϯ 0.4 kDa) is similar to the molecular weight deduced from the A. vinelandii nifQ primary sequence (M r ϭ 19.7 kDa) and thus consistent with a monomeric structure. As-isolated NifQ contained 3.1 Ϯ 0.1 Fe atoms and 0.30 Ϯ 0.04 Mo atoms per NifQ molecule as determined by inductively coupled plasma optical emission spectrometry (ICP-OES). Interestingly, ICP-OES analysis showed that rNifQ contained 4.6 Ϯ 0.2 Fe atoms but no molybdenum. NifQ displayed a UV-visible spectrum typical of [Fe-S] proteins with a sharp peak at 340 nm, a broad peak at 410 nm, and an A 410 /A 280 ratio of 0.2 (Fig. 1D ). This ratio decreased after incubating NifQ with 5 mM sodium dithionite (DTH), which is characteristic of [Fe-S] cluster reduction by DTH. Fig. 2A shows the X-band continuous wave electron paramagnetic resonance (CW-EPR) spectrum of the as-isolated NifQ protein. The spectrum exhibits a fairly isotropic signal centered at g ϭ 2.00 with a peak-to-peak line width of Ϸ27 G (Fig. 2 A magnification) . This EPR signal has an asymmetric shape that is characteristic of a S ϭ 1/2 [3Fe-4S] ϩ cluster (25, 26) ; it exhibits line width similar to that of aconitase (25) and line shape similar to that of ferredoxin II from Desulfovibrio gigas (27) . It has been proposed that the EPR signal of oxidized [3Fe-4S] ϩ clusters arises from the antiferromagnetic exchange coupling of three high-spin (S ϭ 5/2) ferric ions to form an S ϭ 1/2 ground state (26) . Power-and temperature-dependence profiles of the EPR signal from NifQ are also consistent with the presence of [3Fe-4S] ϩ clusters in the as-isolated NifQ (Fig. S1) In conclusion, CW-EPR and ESE field sweep EPR analysis, combined with Fe and Mo determinations, indicate that NifQ is able to coordinate a redox responsive [Mo-3Fe-4S] cluster.
NifQ Serves as a Molybdenum Donor for FeMo-co Synthesis in Vitro.
The assay for in vitro FeMo-co synthesis with purified components used in this work requires a FeMo-co precursor (NifB-co or VK-cluster † † ), NifH, NifEN, homocitrate, Mg-ATP, DTH, and a source of molybdenum (either Na 2 MoO 4 or NifQ). Synthesized FeMo-co binds and activates FeMo-co-deficient apoNifDK protein, generating active NifDK that is routinely assayed by its acetylene-reducing activity.
Fig . 4A shows the titration with NifQ of VK-cluster-dependent in vitro FeMo-co biosynthesis reactions. Because no molybdate was added to the reactions, this result shows that as-isolated NifQ substituted for Na 2 MoO 4 in the assay. Similar results were obtained when NifB-co and precursor-free NifEN [purified from UW243 cells (13) ] were substituted for VK-cluster-loaded NifEN in the assay (data not shown). We note that the background level of apo-NifDK activation observed in the reaction lacking NifQ was because of mobilization of the molybdenum present in purified NifEN preparations (11) .
The level of NifDK-specific activity reconstituted in vitro was limited by several factors. First, at saturating levels of NifQ (10 nmol), the amount of NifEN present in the assay (0.48 nmol) † † The VK-cluster is the [Fe-S] cluster precursor to FeMo-co that accumulates on NifEN in a ⌬nifH mutant strain and is thought to represent an intermediate after NifB-co in FeMo-co synthesis (13) . became limiting. When 2.4 nmol of NifEN were used in the assay, the level of reconstituted NifDK activity and the amount of NifQ required to saturate the assay increased accordingly (data not shown). Second, molybdenum donation by NifQ was incomplete under the in vitro FeMo-co biosynthesis assay conditions. In vitro FeMo-co synthesis reactions in which denatured NifQ protein served as the molybdenum source yielded 2-fold higher NifDK activity levels than reactions in which the same amount of native NifQ served as the molybdenum donor (data not shown). Third, saturating amounts of apo-NifDK were added to the assay to obtain higher absolute levels of apo-NifDK activation at the expense of obtaining lower specific activity per mg of NifDK, as described in ref.
14. NifQ supported the formation of fully functional NifDK protein. In vitro reconstituted NifDK reduced dinitrogen to ammonia with a ratio of specific activity of ammonia-to-ethylene production similar to native NifDK (Fig. 4A) . This ratio was different from those of the alternative nitrogenases (especially the iron-only nitrogenase), demonstrating that NifQ mostly supported the synthesis of FeMo-co and not that of the analogous cofactor FeFe-co.
Neither purified rNifQ, determined to be molybdenum-free by ICP-OES, nor the molybdoprotein nitrate reductase (NarB) were able to activate the apo-NifDK in parallel assays (Fig. 4A) . Purified NarB contained 1 mol of Mo per mol of protein and was fully active in a methyl-viologen-dependent nitrate reductase activity assay (31) (data not shown). The fact that the molybdenum-free NifQ and the molybdoprotein NarB could not activate apo-NifDK suggested that (i) the molybdenum-loaded form of NifQ was specifically required for FeMo-co synthesis and (ii) NarB could not act as a source of molybdenum for FeMo-co synthesis.
The effect of NifQ in apo-NifDK activation was less pronounced when a subsaturating amount of molybdate was additionally included in the reaction mixture and was very small in a reaction additionally containing a saturating amount of molybdate (Fig. 4B) . Thus, NifQ could serve as a molybdenum donor as well as molybdate in the in vitro FeMo-co synthesis assay. Fig. 4C shows the effect of omitting specific protein components from the apo-NifDK activation mixture in reactions lacking molybdate. The reaction containing NifQ showed maximal NifDK activity, whereas the reaction lacking NifQ exhibited 20% of such a maximum. The NifDK activity observed in the reconstituting reaction lacking NifQ has been reported (11) and attributed to the presence of substoichiometric amounts of molybdenum in purified NifEN that are incorporated into FeMo-co. Reactions carried out in the absence of either NifEN, NifH, apo-NifDK, or homocitrate showed very low NifDK activities, indicating their requirement for apo-NifDK activation using NifQ as the molybdenum donor.
Mobilization of Molybdenum from NifQ Requires the Simultaneous
Presence of NifH and NifEN Proteins. The features of the stimulatory effect of NifQ on apo-NifDK activation shown in Fig. 4A demonstrate that the molybdenum carried by NifQ was used for FeMo-co synthesis in vitro. However, the identity of the molybdenum acceptor protein(s) in the reaction remained unclear. To investigate this aspect, as-isolated NifQ samples were incubated under FeMo-co synthesis conditions in the presence of either (i) NifH, (ii) NifEN, (iii) NifH and NifEN, or (iv) NifH, NifEN, and apo-NifDK. After incubation, the protein components of each reaction mixture were reisolated by chromatography (Fig. S2) and their molybdenum contents were determined by ICP-OES. The result of this analysis is shown in Table 1 .
The molybdenum content of NifQ was not significantly affected after incubation with NifH or NifEN. Likewise, the molybdenum content of either NifEN or NifH was unaltered by incubation with NifQ. These results suggest a lack of molybdenum exchange between NifQ and NifH or between NifQ and NifEN.
On the other hand, a major alteration in the molybdenum distribution among NifQ, NifH, and NifEN occurred when all three proteins were incubated together under FeMo-co synthesis conditions and then reisolated (Table 1) . Upon reisolation, the molybdenum content of NifQ was Ͼ3-fold lower, with a concomitant significant increase in the molybdenum content of both NifEN and NifH. The addition of apo-NifDK as a ''sink'' of in vitro synthesized FeMo-co did not seem to further stimulate mobilization of molybdenum from NifQ toward NifEN/NifH.
In conclusion, significant mobilization of molybdenum from NifQ required simultaneous incubation with NifH and NifEN under FeMo-co synthesis conditions. Donation of molybdenum from NifQ contributed to FeMo-co synthesis, as demonstrated by its ability to activate apo-NifDK when included in the reaction mixtures (Fig. 4 and Table 1 ).
Discussion
Molybdenum is normally present in the environment as trace amounts of molybdate (Ͻ50 nM) or as highly insoluble minerals such as molybdenite (MoS 2 ) or wulfenite (PbMoO 4 ) (32). Consequently, microorganisms have developed different strategies to cope with molybdenum limitation. A model microorganism with which to study molybdenum uptake and metabolism is A. vinelandii, which carries Mo-co-containing enzymes and nitrogenase. A. vinelandii expresses several high-affinity molybdatetransport systems, a Mosto, and additional proteins involved in molybdenum trafficking for the biosynthesis of FeMo-co and Mo-co. One such protein is NifQ, for which genetic evidence has suggested a role in molybdenum processing for nitrogenase.
Alignment of NifQ amino acid sequences from a variety of bacteria shows a conserved C-terminal region including a Cx 4 Cx 2 Cx 5 C motif suggested to be a metal cluster binding site (Fig. S3) . Herein, we provide definitive evidence for the presence of metal cluster(s) on NifQ.
The CW-EPR spectrum of as-isolated NifQ resembles a [3Fe-4S] ϩ -containing protein (25) , whereas the EPR spectrum of DTH-reduced NifQ resembles model compounds having a Purified as-isolated NifQ was incubated with purified (i) NifH, (ii) NifEN, (iii) NifH and NifEN, or (iv) NifH, NifEN and apo-NifDK in reaction mixtures that also contained Mg-ATP, DTH, and homocitrate. No external source of molybdenum was added to the mixtures. NifQ, NifH, and NifEN proteins were reisolated by chromatography after incubation. Molybdenum content was quantified by ICP-OES and is shown in mol of molybdenum per mol of protein (i.e. NifQ monomer, NifH dimer, or NifEN tetramer). Values are the average of at least two independent determinations Ϯ SD.
[Mo-3Fe-4S] 3ϩ cluster unit (28) (29) (30) . Two interpretations can be considered to rationalize these observations. Why is the as-isolated NifQ protein loaded with substoichiometric amounts of molybdenum? There are three nonexclusive possible explanations. First, as-isolated NifQ might represent a snapshot of molybdenum trafficking through NifQ during active FeMo-co synthesis. Second, molybdenum binding to NifQ might be labile under purification conditions. Third, because NifQ is present at very low levels in nitrogenase-derepressed A. vinelandii wild-type cells (data not shown), strain UW300, which overexpresses a his-tagged variant of NifQ, was used in this study. NifQ overexpression in UW300 cells might have overwhelmed the capacity of the cells to load NifQ with molybdenum.
Interestingly, NifQ expressed and purified from E. coli cells (rNifQ) was found to be a molybdenum-free [4Fe-4S]-clustercontaining protein. The CW-EPR spectrum of DTH-reduced rNifQ, recorded at 12 K, showed an axial EPR signal (g 1 ϭ g 2 ϭ 2.05 and g 3 ϭ 1.92) with a line shape typical of [4Fe-4S] ϩ clusters (Fig. S4) . In addition, temperature-and power-dependence profiles of this EPR signal were indicative of the presence of a [4Fe-4S] ϩ cluster in rNifQ (power dependence shown in Fig.  S5 ). These observations suggest that the loading of molybdenum into NifQ is carried out by a specific mechanism in A. vinelandii (a mechanism that is absent in E. coli) rather than by a process in which NifQ captures free molybdate from the cytoplasm.
The present study shows a clear linkage between NifQ and molybdenum trafficking for nitrogen fixation. NifQ served as direct source of molybdenum for FeMo-co biosynthesis in vitro. The role of NifQ appears to be in substituting sulfur by oxygen ligands to the molybdenum atom by incorporating it into an [Fe-S] cluster frame. This role is consistent with previous genetic evidence showing suppression of a nifQ mutant phenotype by cystine in the growth medium (34) . It is not clear why molybdate can substitute for NifQ in the in vitro FeMo-co biosynthesis assay, but it is possible that molybdate reacts in vitro with excess DTH (35) , thus generating Mo-S compounds suitable for FeMo-co synthesis.
The requirement for the simultaneous presence of NifH and NifEN in the reaction suggests that a NifEN/NifH complex could be required to unload the molybdenum from NifQ. Neither NifH nor NifEN alone were capable of mobilizing molybdenum from NifQ. These results also suggest specificity in the process of molybdenum transfer rather than leakage of molybdenum from NifQ into the solvent followed by capture of molybdenum by another protein. The ability of NifEN to associate with wild-type NifH can be inferred from the observation that a NifH mutant variant (L127⌬) forms a stable complex with a form of NifEN that is loaded with a FeMo-co precursor (36) . Such a FeMo-co precursor, denominated as the VK-cluster, appears to be a molybdenum-free complex [Fe-S] cluster (13, 37) .
Determination of the entry point of molybdenum into the pathway for FeMo-co biosynthesis has been elusive. In vitro FeMo-co synthesis reactions using Na 2 MoO 4 as source of molybdenum showed mutual NifH and NifEN dependence in the incorporation of molybdenum into FeMo-co precursors (38, 39) . Based on these results, NifH was suggested to be an entry point for molybdenum (38) or even asserted to be a molybdenum/ homocitrate insertase (39) . On the other hand, the existence of a NifH-independent molybdenum binding site within NifEN was proposed based on the presence of substoichiometric amounts of molybdenum in NifEN purified from a ⌬nifH strain (11) . Molybdenum within NifEN was shown to be part of a [Mo-Fe-S] cluster different from the previously characterized FeMo-co precursor VK-cluster (12) and thought to represent a transient site for intramolecular molybdenum donation toward the VKcluster. However, these observations could not rule out a NifH's possible role in enhancing molybdenum binding into this transient site in NifEN.
This study provides strong evidence indicating that molybdenum trafficking for FeMo-co synthesis involves the specific donation of molybdenum from NifQ to NifEN/NifH. Although genetic and biochemical evidence shows that excess molybdate can substitute for NifQ, this protein has an essential role when the levels of molybdenum available for FeMo-co synthesis are low. This result accredits NifQ as a physiological molybdenum donor and suggests that a putative NifEN/NifH complex might be the molybdenum acceptor during FeMo-co biosynthesis. The chemistry underlying this process and specifically whether or not NifQ transfers the entire [Mo-3Fe-4S] cluster remains to be elucidated.
Experimental Procedures
Expression and Purification of NifQ from A. vinelandii. NifQ was purified from cell-free extracts of A. vinelandii strain UW300 (P nifH::his9-nifQ) by affinity chromatography to a Co 2ϩ resin (Talon resin, Clontech) under anaerobic conditions inside a glove box. Buffers for protein purification and analysis were sparged with purified N2 for 20 -30 min. The A. vinelandii cell-free extracts were prepared by osmotic shock according to ref. 40 , followed by centrifugation at 30,000 ϫ g for 1 h to remove cell debris. Cell-free extracts were loaded onto a 20-ml Co 2ϩ -affinity column equilibrated in buffer A [10 mM sodium phosphate, 1.8 mM potassium phosphate buffer (pH 7.3), 140 mM NaCl, 2.7 mM KCl, 10% glycerol]. The column was washed with 200 ml of buffer B [50 mM Tris-HCl buffer (pH 7.9), 500 mM NaCl, 25 mM imidazole], and the NifQ protein was eluted from the column by applying 40 ml of buffer C [50 mM Tris-HCl buffer (pH 7.9), 150 mM NaCl, 300 mM imidazole]. Eluted NifQ was concentrated by ultrafiltration through a YM10 membrane in an Amicon cell under a N 2 atmosphere and then subjected to a cycle of dilutionconcentration in buffer D [50 mM Tris-HCl buffer (pH 7.9), 150 mM NaCl] to remove the residual imidazole. A typical purification procedure yielded 100 mg of NifQ from 340 g of UW300 cell paste. NifQ preparations were estimated to be Ͼ95% pure based on SDS/PAGE analysis. The preparations of purified NifQ were frozen as droplets into liquid nitrogen until use.
In Vitro FeMo-co Synthesis Assays with Purified Components. The in vitro FeMo-co synthesis reactions were performed in 9-ml serum vials sealed with rubber stoppers. All of the vials were acid-washed overnight in 4 M HCl and thoroughly rinsed with Milli-Q water (Millipore) before use. The vials were repeatedly evacuated and flushed with argon gas and finally rinsed with 0.3 ml of anaerobic 25 mM Tris-HCl (pH 7.5), 1 mM DTH. The complete reactions contained 25 mM Tris-HCl (pH 7.5), 0.182 mM homocitrate, 2.92 mM DTH, 3.3% glycerol, an ATP-regenerating mixture (1.32 mM ATP, 18.7 mM phosphocreatine, 2.27 mM MgCl2, 45.4 g/ml creatine phosphokinase), 150 g of NifH (2.4 nmol), 100 g of apo-NifDK (0.43 nmol), and 100 g of NifEN (0.48 nmol) as a source of FeMo-co precursor (purified NifEN protein carries the VK-cluster). When indicated, Na2MoO4, purified NifQ, rNifQ, or NarB were used as a source of molybdenum in the reaction. The reactions (total volume of 350 l) were incubated at 30°C for 35 min to allow for the FeMo-co synthesis and insertion reactions. The resulting activation of apo-NifDK was analyzed by the acetylene reduction assay after addition of 0.2 mg of NifH and 0.8 ml of ATP-regenerating mixture (41) . Ammonia production by activated apo-NifDK was determined as described (14) .
Analysis of Molybdenum Transfer Among NifQ, NifH, and NifEN. In vitro FeMo-co synthesis mixtures were scaled up Ϸ20-fold to a volume of 7 ml, keeping the concentration of all chemicals constant. Na2MoO4 was omitted from the reaction mixtures, and all vials were acid-washed and thoroughly rinsed with Milli-Q water to remove molybdenum traces. Two hundred nanomoles of NifQ were mixed with either (i) 112 nmol of NifH, (ii) 9.6 nmol of NifEN, (iii) 112 nmol of NifH plus 9.6 nmol of NifEN, or (iv) 112 nmol of NifH, 9.6 nmol of NifEN, and 8.6 nmol of apo-NifDK. Reactions mixtures were incubated for 35 min at 30°C under conditions of in vitro FeMo-co synthesis, and then the proteins in each mixture were separated by chromatography as follows. NifQ and NifH mixtures were separated by chromatography in Co 2ϩ affinity resin, which binds NifQ but not NifH. NifH was then desalted by gel filtration on a PD-10 column (GE Healthcare). NifQ and NifEN were separated by preparative gel filtration on a HiLoad 16/60 Sephadex 200 PG column (GE Healthcare). NifQ, NifH, and NifEN were separated by sequential chromatography in Co 2ϩ affinity resin and preparative gel filtration on a HiLoad 16/60 Sephadex 200 PG column. Finally, when the mixture contained NifQ, NifH, NifEN, and apo-NifDK, NifQ was separated by affinity chromatography on a Co 2ϩ resin followed by preparative gel filtration on a HiLoad 16/60 Sephadex 200 PG column. In all cases, reisolated proteins were concentrated in Centricon devices (Amicon) and stored as droplets in liquid nitrogen.
To determine the molybdenum content associated with each isolated component, protein samples were heat-denatured and centrifuged, and the supernatant was analyzed by ICP-OES as described in SI Experimental Procedures. EPR Spectroscopy. X-band CW-EPR spectra were obtained by using a Bruker ECS106 spectrometer equipped with an ER4116DM dual-mode X-band cavity. Cryogenic temperature was obtained by using an Oxford Instrument ESR900 liquid helium flow cryostat, and temperature was controlled by using an ITC503 temperature controller (Oxford Instruments). ESE-detected EPR spectra were recorded on the Bruker Elexsys using the EN4118x-MD4 probe. ESE-EPR was collected by using the two-pulse sequence /2----echo. The /2 pulse was set to 16 ns, and ranged from 136 -144 ns.
Additional methods, including the strains used in this work (Table S2) , are detailed in SI Experimental Procedures.
